Our Team
Brian W. Boyle, MD
Brian is Founder and CEO of Measured Wellness. He is an attending psychiatrist in the Neurotherapeutics Department at McLean Hospital, where he treats patients with severe mental illness using modalities such as electroconvulsive therapy and ketamine. He completed his adult psychiatry residency training at MGH and McLean Hospitals, serving as Chief Resident of Psychotherapy and the Program in Psychodynamics.
Brian completed a fellowship at the Boston Psychoanalytic Society and Institute (BPSI) and trained in the Mentalization Based Treatment (MBT) clinic at McLean Hospital. Brian is currently the Affiliate Psychiatrist at Two Brattle Center, a multidisciplinary consultation team that treats patients with personality disorders using evidence-based approaches such as dialectical behavioral therapy (DBT). Additionally, he practices family therapy in consultation to the Gunderson program at McLean Hospital.
A former finalist in the Harvard Innovation Lab's Dean's Health and Life Sciences Challenge, Brian has a strong interest in working with entrepreneurs and has served as Executive Coach in Residence at Techstars Boston, a premier startup incubator. Having studied systems psychodynamics at BPSI and led interpersonal groups for years, he employs a team-based approach to help founders succeed through insight into group process.
Brian graduated from Yale College with an honors degree in philosophy and earned his MD from Harvard Medical School.
Danielle Walker, Psychiatric NP
Danielle is a board-certified Nurse Practitioner in psychiatry and mental health (PMHNP-BC). She can extensive experience working with individuals of all ages, providing medication management and psychotherapy for a wide range of mental health conditions including but limited to depression, anxiety, bipolar disorder, ADHD, and trauma. She is committed to providing holistic and evidence-based care. Her approach to medication is collaborative and conversational, providing a low-pressure and client-centered environment to discuss treatment options.
Danielle completed her training at Boston College. She is currently a NP at Boston Medical Center/Boston Emergency Services Team. Prior to completing her Master’s degree, Danielle worked as a psychiatric registered nurse at McLean Hospital and Massachusetts General Hospital. She has also taught undergraduate nursing students for Northeastern University and MCPHS University. She is currently enrolled at Boston College in a PhD program.
In her free time, Danielle enjoys spending time with family and frequenting local restaurants.
David Mou, MD MBA
David is a Co-founder of Measured Wellness, where he was a former clinician. He is currently the Chief Medical Officer for Cerebral, where he leads the clinical team and serves as Principal Investigator for clinical trials with pharmaceutical companies. David is the Director of the Innovations Council for Massachusetts General Hospital's Psychiatry Department. He serves on the Neuroscience Executive Council for Janssen Pharmaceuticals.
David earned his BA , MD, and MBA from Harvard. He completed his clinical training at MGH and McLean hospitals. His writings have appeared in the New England Journal of Medicine and Stat.
Emma Beck
Emma is the Director of Operations at Measured Wellness. Prior to joining the Measured team, she worked at several health tech start ups, like Collective Health, Two Chairs, and Brightline, where she held roles in product management, operations, and strategy. She is also the founder of Moss Health, a startup offering tools for specialty mental health providers and care companions for their patients.
Emma earned MBA from Harvard Business School and loves hiking and skiing with her dog, Nala, a brown, fluffy, Newfoundland-Poodle mix.
Measured Wellness is now Stella
Dr Boyle has joined Stella Center as Chief Psychiatry Officer and continues to provide the highest standard of care to those experiencing depression, anxiety, and PTSD/PTSI. Measured Wellness is now known as Stella's Boston Center of Excellence, offering Spravato ketamine therapy, the Dual Sympathetic reset, and soon transcranial magnetic stimulation (TMS).